|
Abstract
|
|
Retinal
fluoroangiography (FA) has revolutionised the diagnosis and treatment
of many retinal diseases. In the case of the diagnosis of age-related
macular degeneration (AMD), it has facilitated the identification
of drusen, atrophic areas and choroidal neovascular membranes, the
last of which are the worst complication of the disease and can be
better treated because FA is capable of locating them and defining
their borders. The Macular Photocoagulation Study (MPS)* improved
the interpretation of fluoroangiograms containing neovascular lesions,
and the recently introduced treatment of age-related macular degeneration
with photodynamic therapy (TAP)** has allowed their further differentiation
on the basis of treatment response. |
|
Leadership Medica® |
